Latka logo
Cagent Vascular logo

Cagent Vascularrevenue

Wayne, PennsylvaniaFounded 2014CEO Brian Walsh

Cagent Vascular Inc. is a developer of next generation angioplasty balloons using Serration Technology for the treatment of cardiovascular disease.

cagentvascular.comLinkedInUpdated Sep 10, 2026
Annual revenue
$25.4M
Sep 2025EST
Employees
72
Sep 2025

Cagent Vascular revenue

Cagent Vascular has not published its revenue. Growjo puts it at about $25.4M a year (September 2025).

$0
$10M
$20M
$0
–
$25.4M
20142015–242025
ReportedEstimateFounded 2014 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$25.4MESTGrowjo estimate

Cagent Vascular CEO & employees

Brian Walsh is CEO of Cagent Vascular. Cagent Vascular has 72 employees (September 2025, LinkedIn).

0
20
40
60
72
2025
ReportedOne figure per year; a reported figure wins over an estimate

Cagent Vascular FAQ

What is Cagent Vascular's revenue?

Growjo estimates Cagent Vascular's revenue at about $25.4M a year (September 2025). The company hasn't published its own figure.

How many employees does Cagent Vascular have?

Cagent Vascular has 72 employees as of September 2025, according to LinkedIn.

Who is the CEO of Cagent Vascular?

Brian Walsh is the CEO of Cagent Vascular.

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Cagent Vascular? Join the podcast